Adam Sherwat, the director of the Office of Infectious Diseases in the FDA's Center for Drug Evaluation and Research, is leaving the agency. The departure was announced today, though specific timing and reasons for his exit were not disclosed.
Sherwat's office plays a critical role in evaluating drugs and treatments for infectious diseases, including antibiotics, antivirals, and vaccines. His departure comes at a time when the FDA continues to oversee ongoing public health challenges and drug approval processes.